文献速递炎症性肠病肝病胃肠动力与功能性疾病

大麻及其衍生物在胃肠与肝脏疾病中的作用

Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease.
PubMed 文献 · Gastroenterology · 2020-04-22

过去十年医用和娱乐用大麻使用显著增加,其通过内源性大麻素系统影响胃肠稳态,具有抗炎、镇痛和抗分泌作用;但人体研究较少,大麻可缓解化疗所致恶心呕吐和慢性疼痛,也对代谢、肥胖、非酒精性脂肪性肝病及炎症性肠病有潜在作用,同时存在大麻素剧吐综合征等不良反应。

要点

  • 内源性大麻素系统通过抗炎、镇痛和抗分泌作用影响胃肠稳态。
  • 大麻素可缓解化疗所致恶心呕吐和慢性疼痛。
  • 大麻素剧吐综合征等不良反应可限制其使用。

核心结论

  • 大麻及其衍生物通过内源性大麻素系统对胃肠和肝脏疾病具有潜在治疗作用,但人体研究有限且存在不良反应限制其使用。

研究设计与样本

  • 综述,总结内源性大麻素系统及大麻及其衍生物对胃肠和肝脏功能在健康与疾病状态下的影响。

主要发现

  • 内源性大麻素系统通过抗炎、抗伤害感受和抗分泌效应影响胃肠稳态。
  • 大麻素可缓解化疗诱导的恶心呕吐和慢性疼痛。
  • 内源性大麻素系统在代谢、肥胖和非酒精性脂肪性肝病中起重要作用。
  • 大麻的抗炎作用已在炎症性肠病患者中研究。
  • 大麻素剧吐综合征可影响部分使用者。

临床怎么用

  • 大麻素可用于缓解化疗诱导的恶心呕吐和慢性疼痛。

局限性

  • 细胞和动物研究多,但评估大麻素治疗效应的人体研究少。
  • 大麻的一类管制药品地位限制了其在研究中的可获得性。
  • 大麻仅在部分州近期合法化用于医疗和/或娱乐用途。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Medical and recreational cannabis use has increased dramatically over the last decade, resulting from mainstream cultural acceptance and legalization in several countries worldwide. Cannabis and its derivatives affect many gastrointestinal processes via the endocannabinoid system (ECS). The ECS influences gastrointestinal homeostasis through anti-inflammatory, anti-nociceptive, and anti-secretory effects. Some gastrointestinal disorders might therefore be treated with cannabinoids. Despite numerous studies in cell lines and animals, few human studies have evaluated the therapeutic effects of cannabinoids. Cannabis' schedule 1 drug status has limited its availability in research; cannabis has been legalized only recently, in some states, for medicinal and/or recreational use. Cannabinoids can alleviate chemotherapy-induced nausea and emesis and chronic pain. Studies have demonstrated the important roles of the ECS in metabolism, obesity, and nonalcoholic fatty liver disease and the anti-inflammatory effects of cannabis have been investigated in patients with inflammatory bowel diseases. Despite its potential benefits, undesired or even detrimental effects of cannabis can limit its use. Side effects such as cannabinoid hyperemesis syndrome affect some users. We review the ECS and the effects of cannabis and its derivatives on gastrointestinal and hepatic function in health and disease.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Gotfried J, Naftali T, Schey R, et al. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease. Gastroenterology. 2020. PMID: 32333910. doi:10.1053/j.gastro.2020.03.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。